Investor Presentaiton
Total shareholders' equity to CET1 capital
Total equity to CET1 capital, at 31 December 2022, $m
Total equity to CET1 capital walk, $m
Strategy
4022 results
Appendix
4022
Total equity
Non-controlling interests
Total shareholders'
equity
196,028
Total equity (per balance sheet)
Non-controlling interests
196,028
3022
185,993
(8,544)
(8,335)
2022
196,690
(8,308)
4Q21
206,777
(8,527)
(8,544)
Total shareholders' equity
187,484
177,658
188,382
198,250
Additional Tier 1
(19,746)
(19,746)
(21,691)
(22,414)
187,484
Total ordinary shareholders' equity
167,738
157,912
166,691
175,836
Foreseeable dividend
(4,436)
(3,926)
(3,548)
(3,655)
Additional Tier 1
(19,746)
Adjustment for insurance / SPE's *.73
(3)
4
Allowable NCI in CET1
4,444
4,272
Total ordinary
shareholders' equity
Foreseeable
dividend
insurance / SPE'S
167,738
CET1 before regulatory adjustments
167,743
158,262
(12,881)
4,392
154,654
(13,449)
4,186
162,918
Prudential valuation adjustment
(1,171)
(1,334)
(1,299)
(1,217)
Intangible assets
(12,141)
(11,082)
(11,746)
(9,123)
(4,436)
Deferred tax asset deduction
(4,235)
(3,528)
(3,274)
(1,520)
Deconsolidation of
Cash flow hedge adjustment
3,601
4,669
2,124
170
(3)
Excess of expected loss
(1,248)
(1,992)
(2,373)
(2,020)
Allowable NCI in CET1
4,444
Own credit spread and debit valuation adjustment
Defined benefit pension fund assets
(412)
(1,589)
(778)
1,571
(5,448)
(5,639)
(6,638)
(7,146)
CET1 before
167,743
regulatory adjustments
Direct and indirect holdings of CET1 instruments
Other regulatory adjustments to CET1 capital
(including IFRS 9 transitional adjustments when
relevant)
(40)
(40)
(40)
(40)
(220)
(340)
(235)
766
Regulatory adjustments
(48,452)
CET1 capital
119,291
Threshold deductions*
Regulatory adjustments
CET1 capital
(27,138)
(48,452)
119,291
(26,630) (14,615) (11,794)
(47,505) (38,874) (30,353)
110,757 115,780 132,565
* These rows include offsetting entries of $12,660m for 3Q22 and $13,200m for 4Q22 relating to the start of equity accounting for our insurance subsidiaries with effect from 3Q22
53View entire presentation